- Home
- CUE vs CODA Comparison
CUE vs CODA Comparison
Compare CUE & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUE | CODA |
|---|---|---|
| Founded | 2014 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.5M | 114.7M |
| IPO Year | 2017 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CUE | CODA |
|---|---|---|
| Price | $26.71 | $11.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | ★ 262.2K | 104.3K |
| Earning Date | 05-13-2026 | 06-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | 15.62 |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $27,466,000.00 | $20,316,161.00 |
| Revenue This Year | N/A | $18.28 |
| Revenue Next Year | N/A | $12.62 |
| P/E Ratio | ★ N/A | $31.03 |
| Revenue Growth | ★ 195.75 | 4.98 |
| 52 Week Low | $0.17 | $7.80 |
| 52 Week High | $45.50 | $18.00 |
Technical Indicators
Market Signals| Indicator | CUE | CODA |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 68.94 |
| Support Level | $24.35 | $10.85 |
| Resistance Level | $33.11 | $12.24 |
| Average True Range (ATR) | 4.34 | 0.39 |
| MACD | 0.39 | 0.11 |
| Stochastic Oscillator | 13.45 | 96.75 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About CODA Coda Octopus Group Inc.
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company operates in three distinct business segments: the Marine Technology business, Acoustic Sensors and Material Business and the Defense Engineering Services Business. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.